Latest News and Insights
Please Visit Often to Stay Current
Featured
Cure Ventures is pleased to welcome Gary Ruvkun, PhD, Nobel Laureate and Professor of Genetics at Harvard Medical School, as the keynote speaker at our 2026 Annual General Meeting.
Filter by:
Cure Ventures is pleased to welcome Gary Ruvkun, PhD, Nobel Laureate and Professor of Genetics...
The technology behind Tasca is complex and the process of forming and growing a company...
Cure Ventures (“Cure”), a life sciences venture capital firm focusing on company formation around groundbreaking...
End of content
No more pages to load
Don't Miss a Beat
Subscribe to Our Email List